您的位置: 首页 > 农业专利 > 详情页

Naphthyridinone derivatives and their use in the treatment of arrhythmia
专利权人:
Novartis AG
发明人:
Barbe, Guillaume,Bebernitz, Gregory Raymond,Gulgeze Efthymiou, Hatice Belgin,Liao, Lv,Ma, Fupeng,Mo, Ruowei,Parker, David Thomas,Peng, Yunshan,Paukert, Stefan,Yamada, Ken,Yasoshima, Kayo,Smith, Nichol
申请号:
AU2020204341
公开号:
AU2020204341A1
申请日:
2020.06.29
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
#$%^&*AU2020204341A120200716.pdf#####: Interwoven NRPortbl DCCSXD 20370812_I.DOCX-26/06/2020 ABSTRACT The present invention provides a compound of formula (1) or a pharmaceutically acceptable salt thereof; (1) wherein R1, R3-R, X 2 and X 3 are as defined herein, a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.WO 2018/073788 PCT/1B2017/056515 113 Figure 1. XRPCoflexampni:e I hdrateorm
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充